Soleus Capital Management »

Fractyl Health shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Fractyl Health (GUTS) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Fractyl Health

Tip: Access up to 7 years of quarterly data

All positions including Fractyl Health held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fractyl Health by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.0M 2.5M 1.59

More positions owned by Soleus Capital Management

Krystal Biotech (KRYS)
Tg Therapeutics (TGTX)
Novocure Ord Shs (NVCR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Anthem (ELV)
Beta Bionics (BBNX)
United Therapeutics Corporation (UTHR)
Terns Pharmaceuticals (TERN)
Celcuity (CELC)
Inspire Med Sys (INSP)
Twist Bioscience Corp (TWST)
Argenx Se Sponsored Adr (ARGX)
Organogenesis Hldgs (ORGO)
BioMarin Pharmaceutical (BMRN)
Cidara Therapeutics Com New (CDTX)

View all positions for Soleus Capital Management

Top funds holding Fractyl Health

Nantahala Capital Management
Silverarc Capital Management
Alyeska Investment Group
Woodline Partners
Catalio Capital Management
Rosalind Advisors
General Catalyst Group Management
Deer Management
HCC Manager
683 Capital Management
Maverick Capital
Soleus Capital Management
Point72 Asset Management
Vanguard Group
M28 Capital Management

View all funds holding Fractyl Health